IYH vs. PBE
IYH (iShares U.S. Healthcare ETF) and PBE (Invesco Dynamic Biotechnology & Genome ETF) are both Health & Biotech Equities funds - IYH tracks the Dow Jones U.S. Health Care Index while PBE tracks the Dynamic Biotech & Genome Intellidex Index (AMEX). Both are passively managed. Over the past 10 years, IYH returned 8.96%/yr vs 7.55%/yr for PBE. A 0.76 correlation means they provide meaningful diversification when combined. IYH charges 0.43%/yr vs 0.59%/yr for PBE.
Performance
IYH vs. PBE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IYH achieves a -4.19% return, which is significantly lower than PBE's 0.58% return. Over the past 10 years, IYH has outperformed PBE with an annualized return of 8.96%, while PBE has yielded a comparatively lower 7.55% annualized return.
IYH
- 1D
- 0.96%
- 1M
- 1.98%
- YTD
- -4.19%
- 6M
- -4.54%
- 1Y
- 13.08%
- 3Y*
- 5.48%
- 5Y*
- 4.59%
- 10Y*
- 8.96%
PBE
- 1D
- 2.04%
- 1M
- 2.68%
- YTD
- 0.58%
- 6M
- 1.15%
- 1Y
- 30.26%
- 3Y*
- 10.44%
- 5Y*
- 3.06%
- 10Y*
- 7.55%
IYH vs. PBE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IYH iShares U.S. Healthcare ETF | -4.19% | 13.16% | 2.99% | 2.14% | -4.46% | 23.41% | 15.56% | 20.80% | 5.80% | 22.27% |
PBE Invesco Dynamic Biotechnology & Genome ETF | 0.58% | 24.84% | 1.10% | 3.71% | -10.83% | 1.54% | 25.66% | 18.65% | -0.19% | 22.28% |
Correlation
The correlation between IYH and PBE is 0.76, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.76 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.70 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.72 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.72 |
Correlation (All Time) Calculated using the full available price history since Jun 24, 2005 | 0.76 |
The correlation between IYH and PBE has been stable across timeframes, ranging from 0.70 to 0.76 - a consistent structural relationship.
IYH vs. PBE - Sectors Allocation Comparison
Sectors
IYH
PBE
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
IYH
PBE
Basic Materials
IYH
-
PBE
-
Communication Services
IYH
-
PBE
-
Consumer Cyclical
IYH
-
PBE
-
Consumer Defensive
IYH
-
PBE
-
Energy
IYH
-
PBE
-
Financial Services
IYH
-
PBE
Industrials
IYH
-
PBE
-
Real Estate
IYH
-
PBE
-
Technology
IYH
-
PBE
-
Utilities
IYH
-
PBE
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IYH vs. PBE — Risk / Return Rank
IYH
PBE
IYH vs. PBE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Healthcare ETF (IYH) and Invesco Dynamic Biotechnology & Genome ETF (PBE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IYH | PBE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.73 | ||
| Sortino ratioReturn per unit of downside risk | -1.01 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 1.28 | -0.12 |
| Calmar ratioReturn relative to maximum drawdown | 1.23 | 2.59 | -1.36 |
| Martin ratioReturn relative to average drawdown | 2.97 | 7.27 | -4.30 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IYH | PBE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.89 | 1.63 | -0.73 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.31 | 0.14 | +0.17 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.54 | 0.30 | +0.23 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.43 | 0.32 | +0.10 |
Drawdowns
IYH vs. PBE - Drawdown Comparison
The maximum IYH drawdown since its inception was -43.12%, smaller than the maximum PBE drawdown of -45.69%. Use the drawdown chart below to compare losses from any high point for IYH and PBE.
Loading charts...
Drawdown Indicators
| IYH | PBE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -43.12% | -45.69% | +2.57% |
Max Drawdown (1Y)Largest decline over 1 year | -10.64% | -11.73% | +1.09% |
Max Drawdown (3Y)Largest decline over 3 years | -17.91% | -22.43% | +4.52% |
Max Drawdown (5Y)Largest decline over 5 years | -17.91% | -34.71% | +16.80% |
Max Drawdown (10Y)Largest decline over 10 years | -28.40% | -37.84% | +9.44% |
Current DrawdownCurrent decline from peak | -7.36% | -3.62% | -3.74% |
Average DrawdownAverage peak-to-trough decline | -8.96% | -16.24% | +7.28% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.41% | 4.17% | +0.24% |
Volatility
IYH vs. PBE - Volatility Comparison
The current volatility for iShares U.S. Healthcare ETF (IYH) is 4.24%, while Invesco Dynamic Biotechnology & Genome ETF (PBE) has a volatility of 5.63%. This indicates that IYH experiences smaller price fluctuations and is considered to be less risky than PBE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IYH | PBE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.24% | 5.63% | -1.39% |
Volatility (6M)Calculated over the trailing 6-month period | 10.32% | 13.27% | -2.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.74% | 18.71% | -3.97% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.92% | 22.54% | -7.62% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.72% | 24.92% | -8.20% |
IYH vs. PBE - Expense Ratio Comparison
IYH has a 0.43% expense ratio, which is lower than PBE's 0.59% expense ratio.
Dividends
IYH vs. PBE - Dividend Comparison
IYH's dividend yield for the trailing twelve months is around 1.30%, more than PBE's 1.05% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IYH iShares U.S. Healthcare ETF | 1.30% | 1.19% | 1.25% | 1.18% | 1.10% | 0.94% | 1.16% | 1.14% | 1.95% | 1.10% | 1.29% | 2.02% |
PBE Invesco Dynamic Biotechnology & Genome ETF | 1.05% | 1.00% | 0.05% | 0.02% | 0.00% | 0.00% | 0.04% | 0.00% | 0.00% | 0.57% | 0.38% | 1.12% |
Frequently Asked Questions
IYH and PBE have a correlation of 0.76, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PBE has higher volatility (5.63%) compared to IYH (4.24%). In terms of maximum drawdown, IYH dropped -43.12% vs PBE's -45.69%.
On 10-year performance, IYH leads with 8.96% vs 7.55% for PBE. On fees, IYH is cheaper at 0.43% per year. On volatility, IYH has been the lower-risk option at 4.24%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, IYH has performed better with a 8.96% return vs 7.55%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IYH is cheaper with a 0.43% expense ratio, compared with 0.59% for PBE.
IYH has the higher dividend yield at 1.30%, compared with 1.05% for PBE.
IYH tracks Dow Jones U.S. Health Care Index, while PBE tracks Dynamic Biotech & Genome Intellidex Index (AMEX). They also come from different issuers: iShares and Invesco. Their fees differ too: 0.43% for IYH and 0.59% for PBE.
PBE currently has the higher Sharpe Ratio (1.63 vs 0.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IYH and PBE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer